Next, the AREG concentrations in different IDH1 mutational status and different malignancy astrocytoma group samples and healthy control group serum samples are presented in Figure 1B. There were no statistically significant differences observed between any groups. This evidence concerns the gene AREG and astrocytoma (excluding glioblastoma).